Signed in as:
filler@godaddy.com
Signed in as:
filler@godaddy.com
All content provided by Empower Trading including the swing trade ideas shared here are for educational and informational purposes only. None of the trade alerts, analyses, or strategies shared should be considered personalized investment advice. Always do your own research and consult a licensed financial advisor.
All alerts are provided for educational and informational purposes only and should not be considered financial or investment advice. Always do your own research and trade based on your individual risk tolerance. Past performance is not indicative of future results.
🏃🚀LEDS high 3.45 high, up 123
🏃🚀GMEX high 2.70, up 125%
🏃🚀SUNE high 4.33, up 90%
🏃🚀VTAK high 1.60, 100%
🏃🚀RKTO high 1.27, 50%
🏃🚀SUNE high 2.74, 25%
🏃🚀JEM high 1..27 21%
✅ HUMA entry: 0.60
🎯 PT1: 0.80–1.30
🎯 PT2: 1.40–1.80
🎯 PT3: 1.90–2.40
🛑 Stop: Below 0.55 or 2%–5% or daily max risk per trade
🚦 Risk Level: 🟡 Medium | Catalyst-Driven | Technical Setup
company develops off-the shelf, implantable bioengineered huma tissues designed to improve treatment of vascular and organ damage, recently won FDA IND clearance for first-in-human coronary bypass, plan to file MAA with Israel Ministry of Health for approval of Acellular Tissue engineered vessel for Arterial Trauma Repair, HC Wainwright raised price target to $4.0 from $3., BTIG price target $3, TD Cowen price target $1, D. Boral capital price target $25, does have mixed shelf, be mindful on next spike
✅ CRDL entry: 1.15–1.20
🎯 PT1: 1.40–1.80 🎯 PT2: 1.90–2.60 🎯 PT3: 2.70–3.50
🚫 Stop: Below 1.00 or 2%–5%, or your maximum daily risk per trade.
🚦 Risk Level: 🟡 Medium | Catalyst-Driven | Technical Setup
recently announced positive phase II ARCHER Trial data for CardioIRx, recently secured USA patent for hear drugs, company focuses on novel anti-inflammatory and anti-fibrotic therapies for heart disease, its lead drug, CardioIRx (an oral cannabidiol formulation) is designed to treat serious cardiac conditions like acute myocarditis and recurrent pericarditis by modulating inflammatory pathways involved in fibrosis and heart damage. First Berlin Equity Research price target $7.50, Canaccord Genuity buy rating, HC Wainwright price target $9, does have mixed shelf
✅ RKTO entry: .75–.80
🎯 PT1: 1.10–1.60 🎯 PT2: 1.70–2.40 🎯 PT3: 2.50–2.90
🚫 Stop: Below .70 or 2%–5%, or your maximum daily risk per trade.
🚦 Risk Level: 🔴 High | Fast Moving | Technical Setup
former $HOTH , company pivoted to AI semiconductor technology, radiation-tolerant computing, space infrastructure, defense applications, recently announced retired NASDA astronaut Col. Robert "Shane" Kimbrough to its Space Advisory Board, Kimbrough was involved with Expedition 50 aboard the International Space Station and $SPCX crew-2 mission
✅ QTEX entry: .85
🎯 PT1: 1.00–1.50 🎯 PT2: 1.60–2.00 🎯 PT3: 2.10–2.80
🚫 Stop: Below .80 or 2%–5%, or your maximum daily risk per trade.
🚦 Risk Level: 🔴 High | Fast Moving | Technical Setup
Company focuses in quantum infrastructure, cryogenic interconnect systems, and advanced electronics manufacturing for quantum computing applications, recently awarded $1M grant by Israel Innovation authority for Quantum RF Dielectric development, also recently received purchase order from Fortune 500 customer for AME system, related material from unnamed UAE Firm, received $580,000 NYU Langone order for FDA-cleared ART100, recently launched research collaboration with Northeastern University on cryogenic quantum interconnects, does have mixed shelf
✅ ZYBT potential entry: 1.30
🎯 PT1: 1.60–1.80 🎯 PT2: 1.90–2.50 🎯 PT3: 2.60–3.00
🚫 Potential Stop: Below 1.10 or 2%–5%, or your maximum daily risk per trade.
🚦 Risk Level: 🔴 High | Fast Moving | Technical Setup
back to support from recent high, company develops, manufactures and sells animal vaccines
✅ VRAX potential entry: 3.00
🎯 PT1: 3.40–3.80 🎯 PT2: 3.90–4.50 🎯 PT3: 4.60–5.00
🚫 Potential Stop: Below 2.70 or 2%–5%, or your maximum daily risk per trade.
🚦 Risk Level: 🔴 High | Fast Moving | Technical Setup
recent ultra small float runner, back to near 52wk low, company focused on cancer and chronic disease, recently signed Forsun Diagnostic supply deal for ImmuneSelect in 6 southeast Asian markets, does have mixed shelf
✅ NNDM Entry: 1.40–1.45
🎯 PT1: 1.80–2.20 🎯 PT2: 2.30–2.80 🎯 PT3: 3.60–3.90
🚫 Stop: Below 1.30 or 2%–5% or daily max risk per trade
🚦 Risk Level: 🔴 High | Fast Moving | Technical Setup
Company focuses on nanotechnology products including coatings, cleaners, and specialty material used in consumer, industrial and electronic applications
✅ BYND Entry: .55
🎯 PT1: .80–1.20 🎯 PT2: 1.30–1.80 🎯 PT3: 1.90–2.40
⛔ Stop: Below .50 or 2%–5% or daily max risk per trade
🚦 Risk Level: 🔴 High | Fast Moving | Technical Setup
drop to 52wk low , previously announced rolling out new Beyond Chicken Pieces variety at Kroger $KR stores recently launched latest Beyond Burger at Hard Rock Cafe and introduced Beyond Beef at retailers across Canada, company produces plant-based meat alternatives, does have mixed shelf
✅ GMEX potential entry: $1.35–1.40
🎯 PT1: $1.60–1.90 🎯 PT2: $2.00–2.60 🎯 PT3: $2.70–3.80
🚫 Below $1.00 or 2%–5% or daily max risk per trade
🚦 Risk Level: 🔴 High | Fast Moving | Technical Setup
recent reverse split, ultra small float, recently received first deployment order under agreement with Australian Hospitality food and Beverage Group, received first deployment order for Bon Vivant 3.0 cooking robot machines, company develops autonomous robotic systems for hospital logistics and healthcare automation, food-service and kitchen robotics, industrial and commercial robotics applications
✅ SUNE potential entry: $2.30–2.35
🎯 Potential PT1: $2.50–2.80 🎯 PT2: $2.90–3.40 🎯 PT3: $3.50–3.90
🚫 Potential Stop: Below $2.00 or 2%–5% or daily max risk per trade
🚦 Risk Level: 🔴 High | Fast Moving | Technical Setup
solar energy company focused on helping homeowners, businesses and municipalities reduce electricity costs through solar power and energy storage
✅ HUBC Entry: $1.05–1.10
🎯 PT1: $1.30–1.80 🎯 PT2: $1.90–2.70 🎯 PT3: $2.80–3.50
⛔ Stop: Below $1.00 or 2%–5% or daily max risk per trade
🚦 Risk Level: 🔴 High | Fast Moving | Technical Setup
recent 1/20 reverse split, AI , cybersecurity focused on confidential computing, cyber-secured infrastructure, data fabric, and protecting sensitive government and enterprise data, avoid holding for the moon, goal is green, not greed, high risk for potential future reverse split, already had multiple reverse splits since 2026
ONCO Entry: $0.80
🎯 PT1: $1.00–$1.40
🎯 PT2: $1.50–$2.80
🎯 PT3: $2.90–$3.30
🚫 Stop: Below $0.60 or 2%–5% or your daily max risk per trade
🚦 Risk Level: 🔴 High | Fast Moving | Technical Setup
company focuses on prostate cancer diagnostic test, recently 1/5 reverse split, ultra small float, recent Realbotix acquisition expected to close in 2nd half of 2026,
✅ ORKT Entry: $1.00
🎯 PT1: $1.20–1.60 🎯 PT2: $1.70–2.30 🎯 PT3: $2.40–2.80
⛔ Stop: Below $1.00 or 2%–5% or daily max risk per trade
🚦 Risk Level: 🔴 High | Fast Moving | Technical Setup
back to support from recent high, AI technology/software company, providing IT consultiing, enterprise software solutions, and a no-code application development platform called eMOBIQ
✅ NRSN Entry: $0.70
🎯 PT1: $0.80–1.40
🎯 PT2: $1.50–1.80
🎯 PT3: $1.90–2.50
⛔ Stop: Below $0.65 or 2%–5%, or your daily max risk per trade
🚦 Risk Level: 🟡 Medium | Catalyst-Driven | Technical Setup
recently announced positive trial results for Alzheimer's drug candidate, D. Boral Capital price target $14, Noble financial buy rating, Alliance Global Partners buy rating, its leading drug candidate, PrimeC, a combination of ciprofloxacin and celecoxib for amyotrophic lateral sclerosis (ALS) has shown positive clinical data in phase 2b, currently being prepared for commercial-scale production, upcoming catalyst: 1) topline data, phase 3, 2nd of half 2026, 2) full lNDS submission later of 2026, 3) phase 2 alzheimer's trial top line expected 2026, company focuses on neurodegenerative diseases, primarily ALS, with additional pipeline programs targeting Alzheimer's and Parkinson's, does have mixed shelf, be mindful on next spike
✅ PRSO potential entry: $.75
🎯 Potential PT1: $1.0 – $1.70
🎯 PT2: $1.80 – $2.50
🎯 PT3: $2.60 – $3.20
🚫 Potential Stop: Below $0.70 or 2%–5% or daily max risk per trade
🚦 Risk Level: 🟡 Medium | Catalyst-Driven | Technical Setup
recently announced delivery shipment of 60GHz modules for drone IFF systems, previously announced collaboration with Virewirx, previously secured $1.1M through inducement offer agreement, ,secured $0.9M order from FWA equipment supplier, partnered with WeLink to expand access to high-speed broadband across dense US metro areas, company focuses on fabless semiconductor/mmWave wireless technology, , Benchmark Co buy rating, price target $3,
✅ CAST entry: 2.90–2.95
🎯 PT1: 3.30–3.70
🎯 PT2: 3.80–4.50
🎯 PT3: 4.60–5.40
🛑 Stop: Below 2.80 or 2%–5% or daily max risk per trade
🚦 Risk Level: 🔴 High | Fast Moving | Technical Setup
back to support from recent high above $12, streaming technology company that develops software platforms helping consumers and businesses aggregate streaming TV services into a single interface, recently signed Starlink Business reseller agreement to offer satellite broadband services, announced FreeCast Cities, a free local streaming platform designed for all 210 U.S television markets, also recently signed WIRE3 to deliver white-label streaming platform for fiber subscribers, partnered with FPUnet to offer streaming platform services to 30,000 Fort Pience-area homes
✅ HITI Entry: $2.10–2.15
🎯 PT1: $2.30–2.70 🎯 PT2: $2.80–3.50 🎯 PT3: $3.60–3.80
🛑 Stop: Below $2.00 or 2%–5% or your daily max risk per trade
🚦 Risk Level: 🔴 High | Fast Moving | Technical Setup
MJ ticker, company focuses on retail and e-commerce best known for operating the Canna Cabana chain across Canada, company also sells accessories, CBD products, recently secured $40 M credit term sheet with Big Canadian Bank, Canaccord price target $7.25, Roth MKM buy rating, Haywood buy rating,
✅
✅ EZGO potential entry: $1.20
🎯 PT1: $1.40–1.80 🎯 PT2: $1.90–2.50 🎯 PT3: $2.60–2.90
🛑 Stop: Below $1.10 or 2%–5% or daily max risk per trade
🚦 Risk Level: 🔴 High | Fast moving | Technical Setup
back to support from recent high, company focused on electric bicycles and scooters, battery and charging technologies, battery recycling and related services, recently received Changzhou regulatory approval to begin operations at completed factory in Jiangsu
✅ LEDS potential entry: 1.50–1.55
🎯 Potential PT1: 1.80–2.00 🎯 PT2: 2.10–2.50 🎯 PT3: 2.60–2.80
🛑 Potential Stop: Below 1.40 or 2%–5% or daily max risk per trade
🚦 Risk Level: 🔴 High | Fast moving | Technical Setup
back to support from recent high, company designs and manufactures LED chips and components used in specialty lighting, UV, industrial and commercial applications
✅ JEM potential entry: 1.05
🎯 Potential PT1: 1.20–1.70
🎯 Potential PT2: 1.80–2.50
🎯 Potential PT3: 2.60–2.90
🛑 Potential Stop: Below 1.00 or 2%–5% or daily max risk per trade
🚦 Risk Level: 🔴 High | Fast moving | Technical Setup
back key support from recent high, company focuses on apparel sourcing and supply chain management, and exploring AI- powered , blockchain-enabled supply-chain platform, ultra small float, recent 1/20 reverse split
✅ RKTO entry: 0.80–0.85
🎯 PT1: 1.20–1.60
🎯 PT2: 1.70–2.40
🎯 PT3: 2.50–2.90
🛑 Stop: Below 0.70 or 2%–5% or daily max risk per trade
🚦 Risk Level: 🔴 High | Fast moving | Technical Setup
back to support from recent high above 2.40, former $HOTH , company pivoted to AI semiconductor technology, radiation-tolerant computing, space infrastructure, defense applications, recently announced retired NASDA astronaut Col. Robert "Shane" Kimbrough to its Space Advisory Board, Kimbrough was involved with Expedition 50 aboard the International Space Station and $SPCX crew-2 mission
✅ HUMA entry: 0.70–0.75
🎯 PT1: 0.80–1.30
🎯 PT2: 1.40–1.80
🎯 PT3: 1.90–2.40
🛑 Stop: Below 0.55 or 2%–5% or daily max risk per trade
🚦 Risk Level: 🟡 Medium | Catalyst-Driven | Technical Setup
company develops off-the=shelf, implantable bioengineered huma tissues designed to improve treatment of vascular and organ damage, plan to file MAA with Israel Ministry of Health for approval of Acellular Tissue engineered vessel for Arterial Trauma Repair, HC Wainwright raised price target to $4.0 from $3., BTIG price target $3, TD Cowen price target $1, D. Boral capital price target $25, does have mixed shelf, be mindful on next spike
✅ SUNE entry: 2.10–2.20
🎯 PT1: 2.50–2.80
🎯 PT2: 2.90–3.40
🎯 PT3: 3.50–3.90
🛑 Stop: Below 2.00 or 2%–5% or your daily max risk per trade
🚦 Risk Level: 🔴 High | Fast moving | Technical Setup
back to near support, solar energy company focused on helping homeowners, businesses and municipalities reduce electricity costs through solar power and energy storage
✅ QTEX entry: 1.60
🎯 PT1: 1.80–2.30
🎯 PT2: 2.40–2.80
🎯 PT3: 2.90–3.50
🛑 Stop: Below 1.40 or 2%–5% or your daily max risk per trade
🚦 Risk Level: 🔴 High | Fast moving | Technical Setup
back to support from recent high, Company focuses in quantum infrastructure, cryogenic interconnect systems, and advanced electronics manufacturing for quantum computing applications, recently awarded $1M grant by Israel Innovation authority for Quantum RF Dielectric development, also recently received purchase order from Fortune 500 customer for AME system, related material from unnamed UAE Firm, received $580,000 NYU Langone order for FDA-cleared ART100,
✅ VTAK entry: 0.80
🎯 PT1: 1.00–2.30
🎯 PT2: 2.40–2.80
🎯 PT3: 2.90–3.50
🛑 Stop: Below 0.75 or 2%–5% or daily max risk per trade
🚦 Risk Level: 🟡 Medium | Catalyst-Driven | Technical Setup
recently announced launch of Flyte Hops Florida, back to support from recent high, small float, recently received new VIVO purchase order from hospital in Slovenia, Previously entered distribution agreement with FuMedica, and announced two patents to be issued by USPTO, previously received Approval for LockeT in the United Kingdom, announced introduction of LockeT product line into Italy, company specializes in medical device based in US, two main products: VIVO system is a non-invasive, ED cardiac mapping system that integrates ECG and imaging data to help localize ventricular arrhythmia origins before procedures, the other is LockeT device, a suture retention tool designed to optimize vascular closure after percutaneous procedures, aiming to speed up hemostasis and patient recovery,
✅ BYND entry: 0.70–0.75
🎯 PT1: 1.00–1.50
🎯 PT2: 1.60–2.00
🎯 PT3: 2.05–2.60
🛑 Stop: Below 0.60 or 2%–5% or daily max risk per trade
🚦 Risk Level: 🔴 High | Fast moving | Technical Setup
recently announced launching its Beyond Steak Filet at Wegmans and HEB, making the product available in physical stores for the first time, also rolling out new Beyond Chicken Pieces variety at Kroger $KR stores recently launched latest Beyond Burger at Hard Rock Cafe and introduced Beyond Beef at retailers across Canada, company produces plant-based meat alternatives, does have mixed shelf
✅ SUGP entry: $0.90
🎯 PT1: $1.00 - $1.60
🎯 PT2: $1.70 - $2.40
🎯 PT3: $2.50 - $2.90
🛑 Stop: Below $0.70 or 2%-5% or daily max risk per trade
🚦 Risk Level: 🔴 High | Fast moving | Technical Setup
company focuses on AI powered Xray, security system installation, recently signed GEZE distributorship deal to expand smart building safety technology offering, recently announced contract to supply and install six Under Vehicle Surveillance System, units at the new Huanggang Port Hong Kong -Shenzhen border crossing, scheduled to open 7/1/2026, also previously won Hong Kong Civil Aviation Department smart site safety contract, partnered with Seetrue to offer AI-powered X-ray screening in Hong Khong, Macau

If you do not agree with any term or provision of our Terms and Conditions, you should not use our Site, Services, Content or Information and exit immediately. Please be advised that your continued use of the Site, Services, Content, or Information provided shall indicate your consent and agreement to our Terms and Conditions. Empower Trading has been made to accurately represent the services and its potential. There is no guarantee that you will earn any money using the strategies or services presented on our website or communication platform. Testimonials on our website are not be interpreted as a promise or guarantee of earnings. The content on this website and on our chat communication platform are for informational and recreational purposes only and is not and should not be construed as professional financial, investment, tax, or legal advice. PSM is not an investment adviser. EmpowerTrading.com is Not An Investment Adviser Community. No information herein or in the chatroom is intended for investment advice. Information including catalysts and alerts should be evaluated carefully for accuracy. Trading decisions should be based on your own due diligence. Trading in penny stocks have large potential rewards but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in these products. Do not trade with money that you cannot afford to lose. The past performance of any trading system, strategy, methodology, or particular trader is not indicative of future results. All content is provided subject to the qualifications and limitations stated in our Terms and Conditions. By subscribing to one of our Membership Plans you agree that you have read, understand, and agree to be bound by our Terms and Conditions, Privacy Policy, Code of Conduct, Refund Policy including the mandatory arbitration of disputes.
Copyright © 2025 Empower Trading - All Rights Reserved.
Privacy Policy | Term and Conditions | Code of Conduct | Refund Policy
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.